Literature DB >> 19536001

Inadequate access to surgeons: reason for disparate cancer care?

Cathy J Bradley1, Bassam Dahman, Charles W Given.   

Abstract

OBJECTIVE: To compare the likelihood of seeing a surgeon between elderly dually eligible non-small-cell lung cancer (NSCLC) and colon cancer patients and their Medicare counterparts. Surgery rates between dually eligible and Medicare patients who were evaluated by a surgeon were also assessed.
METHODS: We used statewide Medicaid and Medicare data merged with the Michigan Tumor Registry to extract a sample of patients with a first primary NSCLC (n = 1100) or colon cancer (n = 2086). The study period was from January 1, 1997 to December 31, 2000. We assessed the likelihood of a surgical evaluation using logistic models that included patient characteristics, tumor stage, and census tracts. Among patients evaluated by a surgeon, we used logistic regression to predict if a resection was performed.
RESULTS: Dually eligible patients were nearly half as likely to be evaluated by a surgeon as Medicare patients (odds ratio [OR] = 0.49; 95% confidence interval = 0.32, 0.77 and odds ratio = 0.59; 95% confidence interval = 0.41, 0.86 for NSCLC and colon cancer patients, respectively). Among patients who were evaluated by a surgeon, the likelihood of resection was not statistically significantly different between dually eligible and Medicare patients.
CONCLUSIONS: This study suggests that dually eligible patients, in spite of having Medicaid insurance, are less likely to be evaluated by a surgeon relative to their Medicare counterparts. Policies and interventions aimed toward increasing access to specialists and complete diagnostic work-ups (eg, colonoscopy, bronchoscopy) are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19536001     DOI: 10.1097/MLR.0b013e31819e1f17

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  5 in total

1.  Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance.

Authors:  Joan L Warren; Eboneé N Butler; Jennifer Stevens; Christopher S Lathan; Anne-Michelle Noone; Kevin C Ward; Linda C Harlan
Journal:  J Clin Oncol       Date:  2014-12-22       Impact factor: 44.544

Review 2.  Lung cancer care: the impact of facilities and area measures.

Authors:  Christopher S Lathan
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Patient preference and contraindications in measuring quality of care: what do administrative data miss?

Authors:  Joan J Ryoo; Diana L Ordin; Anna Liza M Antonio; Sabine M Oishi; Michael K Gould; Steven M Asch; Jennifer L Malin
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

4.  Association of State Certificate of Need Regulation With Procedural Volume, Market Share, and Outcomes Among Medicare Beneficiaries.

Authors:  Tarik K Yuce; Jeanette W Chung; Cynthia Barnard; Karl Y Bilimoria
Journal:  JAMA       Date:  2020-11-24       Impact factor: 56.272

5.  Cancer Treatment for Dual Eligibles: What Are the Costs and Who Pays?

Authors:  Susan G Haber; Florence K L Tangka; Lisa C Richardson; Susan A Sabatino; David Howard
Journal:  Am J Cancer Sci       Date:  2013-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.